Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report From the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-1961
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phase 1 Clinical Trial of a New Antiarrhythmic Drug ME3202.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1988English

Design of the GutHeart-targeting Gut Microbiota to Treat Heart Failure-Trial: A Phase II, Randomized Clinical Trial

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trial Using R

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2018English

The Use of Genomics in Clinical Trial Design

Clinical Cancer Research
Cancer ResearchOncology
2008English

How to Design a Cell or Gene Therapy Clinical Trial: Advice From the FDA

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

The Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG): Challenges of Study Design

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

OP0105 Long-Term Safety of Tocilizumab From Large Clinical Trial and Postmarketing Populations

2017English

Hypothesis Generation and Evaluation in Clinical Trial Design

2011English

Lessons Learned From BATTLE-2 in the War on Cancer: The Use of Bayesian Method in Clinical Trial Design

Annals of Translational Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy